
Ranbosis Pharmaceutical Private Limited
About Ranbosis Pharmaceutical Private Limited
Data last updated:
Ranbosis Pharmaceutical Private Limited was a private limited company based in Bangalore, Karnataka, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2012.
The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2012PTC064896. Its GSTIN is 29AAFCR9754E1ZX (Karnataka).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Mohammad Akhtar Jamal and Suruchi Kumari.
Its last annual general meeting (AGM) was held on 28 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at # 69 Shop – 13 (Sbi Building) P & T Complex Cholanayakanahalli R.T. Nagar, Bangalore, Karnataka, India – 560032.
As per the financials filed for FY 2016, the company reported a revenue of ₹3.17 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹8,455 (net margin 2.7%) and EBITDA of ₹11,512 (EBITDA margin 3.6%).
Company details
Contact details
Ranbosis Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka.
- Registered Address# 69 Shop – 13 (Sbi Building) P & T Complex Cholanayakanahalli R.T. Nagar, Bangalore, Karnataka, India – 560032
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ranbosis Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ranbosis Pharmaceutical Private Limited, buy the company report.
Financials of Ranbosis Pharmaceutical Private Limited
FY 2016 filings availableRanbosis Pharmaceutical Private Limited reported revenue of ₹3.17 Lakh (down 6% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA rose 199% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹11,512 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹8,455 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.6% | |
| Net Profit Margin | 2.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ranbosis Pharmaceutical Private Limited, buy the company report.
Board of directors of Ranbosis Pharmaceutical Private Limited
Ranbosis Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Akhtar Jamal Also directs: Ranbiosis Pharmaceutical Private Limited | Director | 18 Jul 2012 | 14 Years 4 Months | As last reported |
| Suruchi Kumari Also directs: Ranbiosis Pharmaceutical Private Limited | Director | 18 Jul 2012 | 14 Years 4 Months | As last reported |
Peer comparison
Ranbosis Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| First Citizen Pharmaceuticals Private Limited | ₹3.18 Lakh (FY 2023) | New Delhi, Delhi, India | ||||
| Achintya Gamut Organic Private Limited | ₹3.18 Lakh (FY 2023) | -86.0% | Kanpur, Uttar Pradesh, India | |||
| Maroot Veda Private Limited | ₹3.17 Lakh (FY 2024) | Ghaziabad, Uttar Pradesh, India | ||||
| A.N.D Chemicals Private Limited | ₹3.17 Lakh (FY 2017) | 74.0% | Lucknow, Uttar Pradesh, India | |||
| Global Hemo Care Private Limited | ₹3.17 Lakh (FY 2024) | 104.0% | Parwanoo, Himachal Pradesh, India | |||
| Ranbosis Pharmaceutical Private Limitedthis company | ₹3.17 Lakh (FY 2016) | ₹8,455 | 2.7% | -6.0% | Bangalore, Karnataka, India | |
| Hith Pharma Private Limited | ₹3.17 Lakh (FY 2018) | 5936.0% | Delhi, India | |||
| Rmba Chemicals Private Limited | ₹3.16 Lakh (FY 2022) | Jalpaiguri, West Bengal, India | ||||
| Sidisha Chemicals Private Limited | ₹3.16 Lakh (FY 2024) | Vasai, Maharashtra, India | ||||
| Krocus Boutique Private Limited | ₹3.13 Lakh (FY 2025) | 2059.0% | Ahmedabad, Gujarat, India | |||
| Vranta Industries Private Limited | ₹3.13 Lakh (FY 2023) | -27.0% | Mangalore, Karnataka, India |
To see the full peer comparison of Ranbosis Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ranbosis Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ranbosis Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ranbosis Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCR9754E1ZX | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ranbosis Pharmaceutical Private Limited, buy the company report.
Recent activity
Ranbosis Pharmaceutical Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Amir Nehal ceased to be Director on 06 Mar 2019.
Frequently asked questions
Ranbosis Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ranbosis Pharmaceutical was a private limited company based in Bangalore, Karnataka, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2012 and is registered under CIN U24232KA2012PTC064896. The company has been struck off by the Registrar of Companies and is no longer operational.
Ranbosis Pharmaceutical had 2 directors:
- Mohammad Akhtar Jamal - Director
- Suruchi Kumari - Director
The CIN (Corporate Identification Number) of Ranbosis Pharmaceutical is U24232KA2012PTC064896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ranbosis Pharmaceutical is at # 69 Shop – 13 Sbi Building P & T Complex Cholanayakanahalli R.T. Nagar, Bangalore, Karnataka, India – 560032.
Ranbosis Pharmaceutical was incorporated on 18 July 2012. It is registered with the Registrar of Companies, Bangalore.
The latest financial statements of Ranbosis Pharmaceutical on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 28 September 2016. Year-wise statements from 2015 are in the company report.
The GSTIN of Ranbosis Pharmaceutical is 29AAFCR9754E1ZX, registered in Karnataka.
Ranbosis Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Ranbosis Pharmaceutical by revenue are First Citizen Pharmaceuticals Private Limited, Achintya Gamut Organic Private Limited, Maroot Veda Private Limited, A.N.D Chemicals Private Limited, Global Hemo Care Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amir Nehal ceased to be Director on 06 Mar 2019. Mohammad Akhtar Jamal was appointed as Director on 18 Jul 2012. Suruchi Kumari was appointed as Director on 18 Jul 2012.

